Arrowhead Pharmaceuticals Inc (OQ:ARWR)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ARWR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 23/20 Nov 20/20 Bradshaw Curt Direct Ownership Common Stock S - Open market or private sale -15,625 $68.73
Nov 23/20 Nov 19/20 Bradshaw Curt Direct Ownership Common Stock S - Open market or private sale -15,625 $69.39
Nov 20/20 Nov 19/20 San Martin Javier Direct Ownership Common Stock S - Open market or private sale -19,500 $69.39
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -43,505  
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock S - Open market or private sale -17,665 $69.86
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock S - Open market or private sale -25,840 $69.04
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 43,505 $14.54
Nov 2/20 Nov 2/20 Hamilton James C Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 23/20 Oct 23/20 Anzalone Christopher Richard Direct Ownership Common Stock S - Open market or private sale -12,272 $58.57
Oct 23/20 Oct 23/20 Anzalone Christopher Richard Direct Ownership Common Stock S - Open market or private sale -87,728 $58.16
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ARWR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 23/20 Nov 20/20 Bradshaw Curt Direct Ownership Common Stock S - Open market or private sale -15,625 $68.73
Nov 23/20 Nov 19/20 Bradshaw Curt Direct Ownership Common Stock S - Open market or private sale -15,625 $69.39
Nov 20/20 Nov 19/20 San Martin Javier Direct Ownership Common Stock S - Open market or private sale -19,500 $69.39
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -43,505  
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock S - Open market or private sale -17,665 $69.86
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock S - Open market or private sale -25,840 $69.04
Nov 12/20 Nov 9/20 Myszkowski Kenneth Allen Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 43,505 $14.54
Nov 2/20 Nov 2/20 Hamilton James C Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 26/20 Oct 8/20 De Backer Marianne Direct Ownership Common Stock P - Open market or private purchase 500 $50.00
Oct 26/20 Oct 8/20 De Backer Marianne Direct Ownership Common Stock P - Open market or private purchase 500 $50.93
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ARWR

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.